Recent News

• 03.27.2026 - Medtronic Receives FDA Clearance for Stealth AXiS™ Surgical System for Cranial and ENT Procedures
• 03.24.2026 - Medtronic and Merit Medical Systems enter into agreement to offer new, FDA-cleared ViaVerte™ system, a basivertebral nerve ablation treatment for chronic vertebrogenic lower-back pain
• 03.23.2026 - Medtronic OmniaSecure™ defibrillation lead is the first lead of its kind to receive FDA approval for conduction system pacing
• 03.10.2026 - Medtronic to acquire Scientia Vascular, marrying access and therapeutic portfolios for neurovascular care
• 03.06.2026 - MiniMed to begin trading on Nasdaq Global Select Market
• 03.06.2026 - MiniMed announces pricing of initial public offering
• 03.06.2026 - MiniMed announces pricing of initial public offering
• 03.05.2026 - Medtronic announces cash dividend for fourth quarter of fiscal year 2026
• 03.05.2026 - Medtronic announces cash dividend for fourth quarter of fiscal year 2026
• 03.03.2026 - Medtronic CFO Thierry Piéton to speak at upcoming investor conferences

Recent Filings

• 03.27.2026 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 03.24.2026 - 8-K Current report
• 03.09.2026 - S-3ASR Automatic shelf registration statement of securities of well-known seasoned issuers
• 03.05.2026 - 4 Statement of changes in beneficial ownership of securities
• 03.05.2026 - 3 Initial statement of beneficial ownership of securities
• 02.27.2026 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 02.26.2026 - 4 Statement of changes in beneficial ownership of securities